Clinical Course of Patients with Intestinal Behçet’s Disease According to Consensus-Based Diagnostic Categories
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: There have been few studies regarding the prognosis of intestinal Behçet’s disease (iBD) patients according to consensus-based diagnostic categories, which reflects the typicality of intestinal ulcers, the presence of oral ulcers, and the accompanying systemic manifestations. Methods: The medical records of patients who had ileocolonic ulcers with a clinical impression of iBD were reviewed. The patients were categorized according to the diagnostic algorithm at the time of diagnosis. Adverse events were defined as major surgery or admission related to iBD deterioration. Results: A total of 163 patients were included in the study. The male-to-female ratio was 1:1.2, and the mean age at the time of diagnosis was 48.9±15.9 years. The numbers of patients who met the definite, probable, suspected, and nondiagnostic iBD criteria were 19 (11.7%), 61 (37.4%), 38 (23.3%), and 45 (27.6%), respectively. The event-free survival of patients with definite, probable, and suspected iBD was significantly shorter than that of patients with nondiagnostic iBD (p=0.026), while there was no significant difference among the definite iBD, probable iBD, and suspected iBD groups (p=0.596). After excluding patients with nondiagnostic iBD, multivariate analysis showed that anemia, fever, colonic involvement other than the ileocecum, and accompanying hematologic disorders at the time of diagnosis were significantly associated with the development of adverse events. Conclusions: The clinical course of patients with definite, probable, and suspected iBD is distinguished from that of patients with nondiagnostic iBD, but patients with definite, probable, and suspected iBD share similar clinical courses.
Abstract
Background/Aims: There have been few studies regarding the prognosis of intestinal Behçet’s disease (iBD) patients according to consensus-based diagnostic categories, which reflects the typicality of intestinal ulcers, the presence of oral ulcers, and the accompanying systemic manifestations. Methods: The medical records of patients who had ileocolonic ulcers with a clinical impression of iBD were reviewed. The patients were categorized according to the diagnostic algorithm at the time of diagnosis. Adverse events were defined as major surgery or admission related to iBD deterioration. Results: A total of 163 patients were included in the study. The male-to-female ratio was 1:1.2, and the mean age at the time of diagnosis was 48.9±15.9 years. The numbers of patients who met the definite, probable, suspected, and nondiagnostic iBD criteria were 19 (11.7%), 61 (37.4%), 38 (23.3%), and 45 (27.6%), respectively. The event-free survival of patients with definite, probable, and suspected iBD was significantly shorter than that of patients with nondiagnostic iBD (p=0.026), while there was no significant difference among the definite iBD, probable iBD, and suspected iBD groups (p=0.596). After excluding patients with nondiagnostic iBD, multivariate analysis showed that anemia, fever, colonic involvement other than the ileocecum, and accompanying hematologic disorders at the time of diagnosis were significantly associated with the development of adverse events. Conclusions: The clinical course of patients with definite, probable, and suspected iBD is distinguished from that of patients with nondiagnostic iBD, but patients with definite, probable, and suspected iBD share similar clinical courses.
참고문헌 (22)
- Suzuki Kurokawa M, "Behcet’s disease", Clin Exp Med, 4, pp.10~20 (2004)
- Sakane T, "Behçet’s disease", N Engl J Med, 341, pp.1284~1291 (1999)
- Hisamatsu T, "The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease : indication of anti-TNFα monoclonal antibodies", J Gastroenterol, 49, pp.156~162 (2014)
- Kobayashi K, "Development of consensus statements for the diagnosis and management of intestinal Behçet’s disease using a modified Delphi approach", J Gastroenterol, 42, pp.737~745 (2007)
- Lee CR, "Colonoscopic findings in intestinal Behçet’s disease", Inflamm Bowel Dis, 7, pp.243~249 (2001)
- 이현정, "Optimal diagnosis and disease activity monitoring of intestinal Behçet’s disease", Intestinal research, 15(3), pp.311~317 (2017), 대한장연구학회
- Cheon JH, "An update on the diagnosis, treatment, and prognosis of intestinal Behçet’s disease", Curr Opin Rheumatol, 27, pp.24~31 (2015)
- Cheon JH, "Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease", Inflamm Bowel Dis, 17, pp.605~613 (2011)
- Kurokawa MS, "Behçet’s disease", Semin Respir Crit Care Med, 25, pp.557~568 (2004)
- Chang HS, "Isolated terminal ileal ulcerations in asymptomatic individuals : natural course and clinical significance", Gastrointest Endosc, 72, pp.1226~1232 (2010)
- Han M, "Incidence and clinical outcomes of intestinal Behçet’s disease in Korea, 2011-2014 : a nationwide population-based study", J Gastroenterol, 52, pp.920~928 (2017)
- Naganuma M, "Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet’s disease", Inflamm Bowel Dis, 14, pp.1259~1264 (2008)
- Ariyachaipanich A, "Intestinal Behçet’s disease : maintenance of remission with adalimumab monotherapy", Inflamm Bowel Dis, 15, pp.1769~1771 (2009)
- Yasuo Suzuki, "Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study", Intestinal research, 19(3), pp.301~312 (2021), 대한장연구학회[DOI]
- Jung YS, "Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease", Inflamm Bowel Dis, 18, pp.1064~1071 (2012)
- 박재준, "Outcome Predictors for Intestinal Behçet’s Disease", Yonsei Medical Journal, 54(5), pp.1084~1090 (2013), 연세대학교의과대학[DOI]
- Ahn JK, "Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8", Rheumatology(Oxford), 47, pp.1228~1230 (2008)
- Soysal T, "Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature", Rheumatology(Oxford), 53, pp.1136~1141 (2014)
- Shen Y, "High incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of Behçet’s disease associated with myelodysplastic syndrome : a series of 16consecutive Chinese patients from the Shanghai Behçet’s disease database and comparison with the literature", Biomed Res Int, 2018, pp.8535091~ (2018)
- Tada Y, "The association of Behçet’s disease with myelodysplastic syndrome in Japan : a review of the literature", Clin Exp Rheumatol, 24(5 Suppl 42), pp.S115~S119 (2006)
- Kawabata H, "Myelodysplastic syndrome complicated with inflammatory intestinal ulcers : significance of trisomy 8", Intern Med, 45, pp.1309~1314 (2006)
- Yuki Mori, "Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8", Intestinal research, 18(4), pp.469~475 (2020), 대한장연구학회[DOI]